Note: Avedro's revenues are gauged from an analysis of company filings.
Avedro has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
May 11, 2018
Complete list of funding rounds and total amounts in the Company Report
Avedro's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Avedro Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Avedro is developing and marketing.
Avedro's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
CURV Medical services; Surgery; Medical services, namely, a non-surgical procedure using a combination of a cross-linking agent and radiation; Surgery, namely, a surgical procedure using a combination of a cross-linking agent and radiation
BOOST GOGGLES Medical instruments for treating eye conditions and diseases, namely, keratoconus, corneal ectasia, myopia, hyperopia, presbyopia, post cataract residual myopia, and hyperopia; medical apparatus and devices, namely, eyewear, goggles, and masks for controlling a gas content at an eye during a medical procedure and during treatment for an eye condition
WORLD LEADER IN CORNEAL REMODELING Pharmaceutical preparations for the treatment of eye diseases and conditions
Patent applications show Avedro's intellectual property,
its current capabilities and future direction.
Avedro has applied for 37 patents since 2009.
Avedro's most recent patent was filed in October 2017 for Systems And Methods For Delivering Drugs To An Eye.A drug delivery device includes a drug-eluting element defined by a plurality of outer surfaces including a delivery surface and one or more other non-delivery surfaces. The delivery surface is positioned against tissue of an eye and shaped to define an area of targeted tissue to receive a drug. The drug-eluting element holds the drug when the delivery surface is not positioned against the tissue. Responsive to the delivery surface being positioned against the tissue, the drug-eluting element releases the drug to the area of targeted tissue through the delivery surface. The drug delivery device includes one or more barrier structures disposed along the one or more non-delivery surfaces of the drug-eluting element. The one or more barrier structures substantially inhibit release of the drug from the drug-eluting element through the one or more non-delivery surfaces.
Complete list of patent applications
Determine whether Avedro grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Avedro is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Avedro vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Avedro, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Avedro and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.